Performance of ABT Abbott Laboratories | -2.9% in 12m
Compare ABT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Abbott Laboratories with its related Sector/Index XLV
Performance Duell ABT vs XLV
| TimeFrame | ABT | XLV |
|---|---|---|
| 1 Day | -0.02% | 0.25% |
| 1 Week | -1.28% | 0.28% |
| 1 Month | -4.29% | -1.67% |
| 3 Months | -4.68% | -0.77% |
| 6 Months | 12.6% | 10.69% |
| 12 Months | -2.89% | 7.15% |
| YTD | -2.65% | 1.84% |
| Rel. Perf. 1m | -0.21 | |
| Rel. Perf. 3m | -0.59 | |
| Rel. Perf. 6m | -0.04 | |
| Rel. Perf. 12m | -0.99 |
Is Abbott Laboratories a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Abbott Laboratories (NYSE:ABT) is currently (May 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 38.93 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABT as of May 2024 is 93.66. This means that ABT is currently overvalued and has a potential downside of -11.56% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ABT as of May 2024 is 93.66. This means that ABT is currently overvalued and has a potential downside of -11.56% (Sold with Premium).
Is ABT a buy, sell or hold?
- Strong Buy: 12
- Buy: 6
- Hold: 7
- Sell: 0
- Strong Sell: 0
Values above 0%: ABT is performing better - Values below 0%: ABT is underperforming
Compare ABT with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.52% | -2.91% | -5.62% | -28.59% |
| US NASDAQ 100 | QQQ | -1.91% | -3.16% | -5.83% | -38.66% |
| US Dow Jones Industrial 30 | DIA | -2.05% | -3.80% | -1.90% | -19.97% |
| German DAX 40 | DBXD | -0.60% | -3.35% | -6.13% | -15.26% |
| UK FTSE 100 | ISFU | -2.09% | -7.89% | -1.38% | -11.64% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.09% | -8.31% | 10.09% | 7.75% |
| Hongkong Hang Seng | HSI | -5.34% | -12.48% | 14.11% | 11.73% |
| Japan Nikkei 225 | EXX7 | -3.01% | -1.31% | -2.17% | -21.53% |
| India NIFTY 50 | INDA | -1.66% | -5.65% | -6.76% | -30.50% |
| Brasil Bovespa | EWZ | -3.04% | -5.86% | 8.09% | -22.09% |
ABT Abbott Laboratories vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.58% | -1.49% | -7.09% | -41.68% |
| Consumer Discretionary | XLY | -0.12% | -3.77% | 1.23% | -24.70% |
| Consumer Staples | XLP | -1.35% | -6.38% | 0.72% | -4.08% |
| Energy | XLE | 2.68% | 1.33% | 2.63% | -22.26% |
| Financial | XLF | -0.76% | -1.84% | -8.88% | -30.55% |
| Health Care | XLV | -1.56% | -2.62% | 1.88% | -10.04% |
| Industrial | XLI | -0.71% | -1.98% | -9.63% | -28.34% |
| Materials | XLB | -0.46% | -0.80% | -2.84% | -17.59% |
| Real Estate | XLRE | -1.69% | -0.75% | 3.80% | -5.30% |
| Technology | XLK | -2.21% | -2.40% | -5.04% | -37.91% |
| Utilities | XLU | -3.25% | -9.28% | -0.27% | -5.40% |
| Aerospace & Defense | XAR | -2.85% | -5.40% | -3.94% | -26.97% |
| Biotech | XBI | -6.50% | -4.07% | -16.21% | -8.30% |
| Homebuilder | XHB | -1.99% | -1.19% | -25.57% | -52.81% |
| Retail | XRT | -1.58% | -2.62% | -7.50% | -24.65% |
Does Abbott Laboratories outperform its market, is ABT a Sector Leader?
No, over the last 12 months Abbott Laboratories (ABT) made -2.89%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.15%.
Over the last 3 months ABT made -4.68%, while XLV made -0.77%.
No, over the last 12 months Abbott Laboratories (ABT) made -2.89%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 7.15%.
Over the last 3 months ABT made -4.68%, while XLV made -0.77%.
| Period | ABT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -4.29% | -1.67% | -1.38% |
| 3 Months | -4.68% | -0.77% | 4.13% |
| 12 Months | -2.89% | 7.15% | 25.70% |